Kings Point Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
CS
FCM
Kings Point Capital Management's AGN Position: Q1 2020 in Review
Kings Point Capital Management sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 250 shares — an estimated $48K sold.
Kings Point Capital Management first reported a position in AGN in Q2 2014 and held it in 22 quarters. The position peaked at $8.23M in Q4 2015. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.
- Kings Point Capital Management reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
- Kings Point Capital Management sold 250 Allergan plc shares in Q1 2020, an estimated $48K.
- Kings Point Capital Management first reported a position in Allergan plc in Q2 2014 and held it in 22 quarters.
- Kings Point Capital Management's Allergan plc position peaked at $8.23M in Q4 2015.
- 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.
Based on Kings Point Capital Management's 13F filing for Q1 2020, filed 14 May 2020.